Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0107548006
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02441969 | TEVA CANADA LIMITED | ACT METHYLPHENIDATE ER | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Marketed | 02330377 | APOTEX INC | APO-METHYLPHENIDATE ER | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Marketed | 02247734 | JANSSEN INC | CONCERTA | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Marketed | 02470322 | ELVIUM LIFE SCIENCES | FOQUEST | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 55 MG |
Cancelled Pre Market | 02346249 | NT PHARMA CANADA LTD | NTP-METHYLPHENIDATE ER-C | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Cancelled Post Market | 02413752 | PHARMASCIENCE INC | PMS-METHYLPHENIDATE ER | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Approved | 02539039 | SUN PHARMA CANADA INC | TARO-METHYLPHENIDATE ER | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Cancelled Post Market | 02315092 | TEVA CANADA LIMITED | TEVA-METHYLPHENIDATE ER-C | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Application information
Related information
Contact us
Version 4.0.3